19 09, 2023

Qkine collaborates with the Cambridge Stem Cell Institute to facilitate same-day access to key research products for researchers at the Cambridge Biomedical Campus

2023-09-26T07:53:25+00:00September 19th, 2023|News, Press Release, stem cells|

Qkine collaborates with the Cambridge Stem Cell Institute to facilitate same-day access to key research products for researchers at the Cambridge Biomedical Campus

30 03, 2022

Endoderm implants

2022-03-31T15:39:06+00:00March 30th, 2022|organoid news, stem cells|

Implantable endoderm organoids combine synthetic support structures and cells to repair or replace the function of endoderm-derived organs like the pancreas, liver, colon, stomach, intestines, lungs, and gall bladder. Adult cells are notoriously difficult to expand in vitro without loss of function, so many implants have harnessed new technologies based on induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs). Pioneers in the field are working to optimize cell lines and effectively scale manufacture protocols to transition to the clinic and fulfill the promise of these next generation of stem cell therapies.

10 01, 2022

pep talk January 2022

2022-02-24T12:06:46+00:00January 10th, 2022|News, newsletter, Resources, stem cells|

Happy New Year! It’s five years since Marko and I founded Qkine, the time has flown. Highlights have been the wonderful feedback we’ve had from customers and launching innovative products such as the first true animal-free TGFβ1, tag-free thermostable FGF2-G3, and demonstrating the efficacy of HGF NK1 in hepatocyte differentiation.

Title

Go to Top